Clinical pathway for rivaroxaban in patients with cancer-associated thrombosis
Phase of Trial: Phase IV
Latest Information Update: 26 Apr 2017
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Therapeutic Use
- 26 Apr 2017 Status changed from active, no longer recruiting to completed.
- 09 Feb 2016 New trial record
- 08 Dec 2015 Interim results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology.